Sharon Schulzki

Ms. Schulzki is a seasoned industry executive and has been Instrumental in driving multiple high return exit events in orthopedics and spine, including transactions with Synthes, JNJ and Medtronic. She built three highly successful businesses in the spine and CMF spaces, and has held VP or C-Level positions with Stryker, Synthes, JNJ and Macropore. Most recently, Sharon was with Tissue Regeneration Systems Inc, a University of Michigan spin-out company with two core technology platforms; the TRS 3D printed resorbable polymer technology was acquired by Depuy Synthes in 2017 and the nanostructured calcium phosphate coating technology was exclusively licensed to Medtronic Spine and Biologics in 2019. Sharon received a B.S. in Medical Technology from Loyola University, Maryland.